Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Stroke Center, Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Int J Stroke. 2022 Aug;17(7):723-732. doi: 10.1177/17474930221107500. Epub 2022 Jun 28.
One-fifth of strokes occur in the territory of the posterior circulation, but their management, particularly acute reperfusion therapy and neurointervention procedures for secondary prevention, has received much less attention than similar interventions for the anterior circulation. In this review, we overview the treatment of posterior circulation stroke, including both interventions in the acute setting and secondary prevention. We focus on areas in which the management of posterior circulation stroke differs from that of stroke in general and highlight recent advances.Effectiveness of acute revascularization of posterior circulation strokes remains in large parts unproven. Thrombolysis seems to have similar benefits and lower hemorrhage risks than in the anterior circulation. The recent ATTENTION and BAOCHE trials have demonstrated that thrombectomy benefits strokes with basilar artery occlusion, but its effect on other posterior occlusion sites remains uncertain. Ischemic and hemorrhagic space-occupying cerebellar strokes can benefit from decompressive craniectomy.Secondary prevention of posterior circulation strokes includes aggressive treatment of cerebrovascular risk factors with both drugs and lifestyle interventions and short-term dual anti-platelet therapy. Randomized controlled trial (RCT) data suggest basilar artery stenosis is better treated with medical therapy than stenting, which has a high peri-procedural risk. Limited data from RCTs in stenting for vertebral stenosis suggest that intracranial stenosis is currently best treated with medical therapy alone; the situation for extracranial stenosis is less clear where stenting for symptomatic stenosis is an option, particularly for recurrent symptoms; larger RCTs are required in this area.
五分之一的中风发生在后循环区域,但与前循环的类似干预措施相比,后循环的管理,特别是急性再灌注治疗和二级预防的神经介入治疗,受到的关注要少得多。在这篇综述中,我们概述了后循环中风的治疗方法,包括急性治疗和二级预防。我们重点关注后循环中风管理与一般中风管理不同的领域,并强调最近的进展。急性再通治疗后循环中风的效果在很大程度上仍未得到证实。溶栓似乎与前循环一样具有相似的益处和更低的出血风险。最近的 ATTENTION 和 BAOCHE 试验表明,血管内血栓切除术对基底动脉闭塞性中风有益,但对其他后循环闭塞部位的效果仍不确定。缺血性和出血性占位性小脑中风可以从去骨瓣减压术获益。后循环中风的二级预防包括使用药物和生活方式干预措施积极治疗脑血管危险因素,以及短期双联抗血小板治疗。随机对照试验 (RCT) 数据表明,基底动脉狭窄最好通过药物治疗而不是支架治疗来治疗,支架治疗有很高的围手术期风险。来自椎动脉狭窄支架置入术 RCT 的有限数据表明,颅内狭窄目前最好单独用药物治疗;对于有症状性狭窄的情况,情况不太清楚,特别是对于复发性症状,对于该领域,需要更大规模的 RCT。